Full budget row: CM finds support in deputy, DKS

Bengaluru, May 6: Karnataka Chief Minister BS Yediyurappa on Wednesday urged migrant workers to stay back as construction activities have resumed and also announced a Rs 1,610 crores COVID-19 financial package for the state.

The Chief Minister also said that close to one lakh persons, including migrant workers and students, among others, have so far been sent back to their home towns from Karnataka.

"We have sent around one lakh people in 3,500 buses and trains, back to their home towns. I have also appealed to migrant workers to stay as the construction work has resumed now," the Chief Minister said at a press conference on Wednesday.

"A package of Rs 1,610 crores will be released as COVID-19 financial relief. One time compensation of Rs 5,000 will be given to 2,30,000 barbers and 7,75,000 drivers," he added.

During the course of the press conference, the Chief Minister also announced compensation for floriculturists in the state.

New Delhi, Feb 4: "I own my statement," said BJP lawmaker Anant kumar Hedge on Tuesday amid the raging controversy over his remark on Mahatma Gandhi while adding that he has never said anything against the Father of the Nation.

"All related media reports are false. I never said what is being debated over. It is an unnecessary controversy. I own my statement made on February 1, 2020, in Bengaluru. I never made any reference to any political party or Mahatma Gandhi or anybody else, I was just trying to categorise freedom struggle. That's all," Hedge told news agency.

"I am surprised by the discussion around it. What can I say about something that is not there? There is hullabaloo going on without anything. My statement is available in public forum. If anyone wants to see, it is available online and on my website. Show me if I have said anything against Mahatma Gandhi, Nehru and any other freedom fighters," he added.

The BJP leader continued: "That programme was about Savarkar. With due respect of all our freedom fighters, I was just discussing our freedom struggle, there is no confusion or any derogatory comment on freedom struggle or fighters. Unnecessary nuisance has been created."

Hedge stoked a controversy after he had attacked Mahatma Gandhi by calling the freedom struggle led by him a "drama" and also questioned as to how "such people" come to be called 'Mahatma' in India.

"None of these so-called leaders was beaten up by the cops even once. Their independence movement was a big drama. It was staged by these leaders with the approval of the British. It was not a genuine fight. It was an adjustment freedom struggle," he had said.

While several Congress leaders have condemned his remark on the father of the nation, BJP leaders too has distanced themselves from it.

Top leadership in BJP is unhappy with Anantkumar Hegde over his controversial remark on Mahatma Gandhi, party sources had said on Monday, adding that he has been asked to issue an unconditional apology.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.